Lung Cancer
Reports · Lung Resection · ReSECT
Lung Cancer
Diagnosis, staging, lymphadenectomy and disease free survival of the patients operated on for lung cancer.
6,770
Procedures for primary lung cancer
67%
Of the tumours in pathological stage I
28%
Of the patients with invasive mediastinal staging
9.1%
Recurrence in the procedures with follow-up
About this report
How to read the charts
The report describes the oncological features of the procedures recorded since 2023.
01
All the content of this report considers the date of surgery, not the date of data entry.
02
Since 2025, the TNM 9th Edition is used.
03
Wedge resections were only incorporated from 2025 onwards; therefore, comparisons with previous years should be interpreted with caution.
Diagnosis
Diagnosis of the procedures
Diagnosis group of the procedures. The dark bar marks a group that accounts for more than half of them.
Invasive staging
Invasive staging
Technique used for the invasive staging of the mediastinum. Shares under 5% are not labelled.
Lymphadenectomy
Type of lymphadenectomy
Type of lymphadenectomy performed, by clinical stage and by surgical approach.
By clinical stage
By approach
Pathological stage
Pathological stage
Distribution of the pathological stage. The area of each block is proportional to the number of procedures.
Clinical vs pathological
Clinical vs pathological stage
Pathological stage of the tumours of each clinical stage: each column is a clinical stage and its squares are split by pathological stage.
Survival
Disease free survival
Probability of remaining free of recurrence in the 5 years after surgery, by pathological stage.
Supported by
